Ocugen
Clinical trials sponsored by Ocugen, explained in plain language.
-
New eye injection enters human testing for Diabetes-Related vision loss
Disease control Recruiting nowThis is a first-in-human study to check the safety and early signs of effectiveness of a new eye injection called OCU200 for diabetic macular edema, a condition that causes vision loss. The study will enroll up to 24 adults with diabetes and vision loss from this specific eye swe…
Phase: PHASE1 • Sponsor: Ocugen • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
One-Shot gene therapy trial offers hope for young people losing their sight
Disease control Recruiting nowThis study is testing a one-time gene therapy injection called OCU410ST for Stargardt disease, a genetic eye disorder that causes vision loss in children and young adults. The trial will enroll 51 participants, with about two-thirds receiving the injection and the rest being in a…
Phase: PHASE2, PHASE3 • Sponsor: Ocugen • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC